EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma

Bettina Giani iD, René Dörfelt iD, Katrin Hartmann, Florian Sänger

Journal of Clinical Apheresis · 2026-06 · 41 (3)

DOI: 10.1002/jca.70130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Apheresis, online erschienen am 01.05.2026. Verfasst von Bettina Giani und 3 weiteren Autor:innen. Beteiligte Einrichtung: LMU Small Animal Clinic, Center for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Ger…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Diclofenac, Extracorporeal Circulation, Meloxicam. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this in vitro experimental was to determine the utility of hemoadsorption (HA) using the CytoSorb adsorber to remove meloxicam and diclofenac from porcine plasma. For this purpose 12 1‐L aliquots of porcine plasma, 6 units were spiked with 293 μg/mL (262–320 μg/mL) diclofenac and 6 with 42.8 μg/mL (41.4–44.7 μg/mL) meloxicam, respectively. Each unit was processed in a circular setup with the CytoSorb adsorber using the PuriFi HA platform until a recirculated volume of 20 L was reached. Pre‐ and post‐adsorber samples were obtained at seven time points. Percentage reduction, clearance, and change from baseline were calculated. Drug concentrations were compared using Friedmann test with post hoc Dunn's multiple comparison test and Wilcoxon matched pairs rank sum test. p < 0.05 were considered significant. Diclofenac was reduced by a median of 242 mg (204–262 mg; 82.1%; 77.0%–83.6%). Total clearance was 40.5 mL/min (33.2–46.2 mL/min). Clearance at a plasma flow of 100 mL/min decreased from 39.9 mL/min (25.3–46.6 mL/min) at 0.2 L to 6.4 mL/min (−3.8 to 14.8 mL/min) at 20 L. Median reduction of meloxicam was 40.4 mg (38.6–42.2 mg; 94.4%; 93.2%–94.6%); total clearance was 94.38 mL/min (93.2–94.6 mL/min). Clearance at a plasma flow of 100 mL/min decreased from 65.3 mL/min (56.7–71.7 mL/min) at 0.2 L to 3.6 mL/min (−13.0 to 4.2 mL/min) at 20 L. HA using the CytoSorb adsorber successfully removed meloxicam and diclofenac from porcine plasma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalDiclofenacExtracorporeal CirculationMeloxicamHemoperfusionAnimalsHumansIn Vitro TechniquesPlasmaSwine

Stichwörter der Autor:innen

drug eliminationextracorporeal blood purificationextracorporeal circuithemoadsorptionnon‐steroidal anti‐inflammatory drugs

Substanzen

Anti-Inflammatory Agents, Non-SteroidalDiclofenacMeloxicam

Autor:innen und Institutionen

  • LMU Small Animal Clinic, Center for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.

ORCID-Profile: Bettina Giani, René Dörfelt

Zitieren

APA

Giani, B., Dörfelt, R., Hartmann, K., & Sänger, F. (2026). Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma. Journal of Clinical Apheresis, 41(3). https://doi.org/10.1002/jca.70130

Vancouver

Giani B, Dörfelt R, Hartmann K, Sänger F. Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma. Journal of Clinical Apheresis. 2026;41(3). doi:10.1002/jca.70130

BibTeX
@article{Giani2026,
  author = {Giani, Bettina and Dörfelt, René and Hartmann, Katrin and Sänger, Florian},
  title = {Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  volume = {41},
  number = {3},
  doi = {10.1002/jca.70130}
}
Kostenlos starten →